Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Transgene Biotek Financial Results

Transgene Biotek Ltd reported audited financial results for the year ended March 31, 2026. The company recorded a standalone net loss of ₹1.65 Crore for FY26.

Source

BSE filing, NSE: TRABI. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Transgene Biotek Ltd: key numbers

Share price
₹2.36
Market cap
₹17.88 Cr
Revenue (annual)
₹0.21 Cr
Net profit (annual)
₹-1.65 Cr
P/E (TTM)
-11.1×Sector 52.0×
Promoter holding
23.64%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Transgene Biotek Ltd

All →

Other financial results announcements

All →